|
⚲
|
| Keyboard |
| York Michael
✚
|
|
|---|---|
| CIK # | 0001755422 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001755422] | |
| 4 | [0001755422] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Metacrine Inc | |
| York Michael | |
| PhaseBio Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Metacrine Inc MTCR
Common Stock
|
2023-01-26 | Sell | 107,054 | $0.41 | 43,892 |
|
Metacrine Inc MTCR
Common Stock
|
2022-02-27 | Grant | 210,553 | $0.00 | |
|
Metacrine Inc MTCR
Stock option (right to buy) · derivative
|
2022-02-27 | Grant | 210,553 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2021-05-20 | Grant | 2,897 | $2.80 | 8,112 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2021-02-05 | Grant | 36,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2020-11-20 | Grant | 2,662 | $3.00 | 7,986 |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 55,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Employee Stock Option (right to buy) · derivative
|
2019-02-27 | Grant | 45,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-12-11 | Buy | 1,500 | $3.88 | 5,820 |